1-6 of 6
Florian Bassermann
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Targeting CDC42 reduces skeletal degeneration after hematopoietic stem cell transplantation

Theresa Landspersky, Merle Stein, Mehmet Saçma, Johanna Geuder, Krischan Braitsch, Jennifer Rivière, Franziska Hettler, Sandra Romero Marquez, Baiba Vilne, Erik Hameister, Daniel Richter, Emely Schönhals, Jan Tuckermann, Mareike Verbeek, Peter Herhaus, Judith S. Hecker, Florian Bassermann, Katharina S. Götze, Wolfgang Enard, Hartmut Geiger, Robert A. J. Oostendorp, Christina Schreck
Journal: Blood Advances
Blood Adv (2024) 8 (20): 5400–5414.
https://doi.org/10.1182/bloodadvances.2024012879
Published: 2024
Includes: Supplemental data
Journal Articles

Elevated RIPK3 correlates with disease burden in myelofibrosis

Veronika Dill, Celina V. Wagner, Eva C. Keller, Francisco Jose Fernandez-Hernandez, Khalid Shoumariyeh, Timo O. Odinius, Lars Buschhorn, Richard T. Hauch, Christian Suren, Judith S. Hecker, Peter Herhaus, Michael Sandherr, Burkhard Schmidt, Julia Slotta-Huspenina, Florian Bassermann, Ulrike Höckendorf, Stefanie Jilg, Caterina Branca, Sebastian Vosberg, Philipp J. Jost
Journal: Blood Advances
Blood Adv (2023) 7 (7): 1219–1224.
https://doi.org/10.1182/bloodadvances.2021006838
Published: 2023
Includes: Supplemental data
Journal Articles

sCD25 as an independent adverse prognostic factor in adult patients with HLH: results of a multicenter retrospective study

Clinical Trials & Observations
Thomas Wimmer, Raphael Mattes, Hans-Joachim Stemmler, Fabian Hauck, Hendrik Schulze-Koops, Stephanie-Susanne Stecher, Michael Starck, Clemens-Martin Wendtner, Peter Bojko, Marcus Hentrich, Katharina E. Nickel, Katharina S. Götze, Florian Bassermann, Michael von Bergwelt-Baildon, Karsten Spiekermann
Journal: Blood Advances
Blood Adv (2023) 7 (5): 832–844.
https://doi.org/10.1182/bloodadvances.2022007953
Published: 2023
Includes: Supplemental data
Journal Articles

SUMOylation inhibition overcomes proteasome inhibitor resistance in multiple myeloma

Guus J. J. E. Heynen, Francis Baumgartner, Michael Heider, Upayan Patra, Maximilian Holz, Jan Braune, Melanie Kaiser, Isabell Schäffer, Stefanos A. Bamopoulos, Evelyn Ramberger, Arunima Murgai, Yuen Lam Dora Ng, Uta Margareta Demel, Dominik Laue, Sven Liebig, Josefine Krüger, Martin Janz, Axel Nogai, Markus Schick, Philipp Mertins, Stefan Müller, Florian Bassermann, Jan Krönke, Ulrich Keller, Matthias Wirth
Journal: Blood Advances
Blood Adv (2023) 7 (4): 469–481.
https://doi.org/10.1182/bloodadvances.2022007875
Published: 2023
Includes: Supplemental data
Journal Articles

MCT1 is a predictive marker for lenalidomide maintenance therapy in multiple myeloma

Clinical Trials & Observations
Jacob Stroh, Anja Seckinger, Michael Heider, Martina Rudelius, Ruth Eichner, Markus Schick, Jolanta Slawska, Martina Emde-Rajaratnam, Hans Salwender, Uta Bertsch, Hartmut Goldschmidt, Katja Weisel, Christof Scheid, Ulrich Keller, Dirk Hose, Florian Bassermann
Journal: Blood Advances
Blood Adv (2022) 6 (2): 515–520.
https://doi.org/10.1182/bloodadvances.2021005532
Published: 2022
Includes: Supplemental data
Journal Articles

Direct modulation of the bone marrow mesenchymal stromal cell compartment by azacitidine enhances healthy hematopoiesis

Catharina Wenk, Anne-Kathrin Garz, Sonja Grath, Christina Huberle, Denis Witham, Marie Weickert, Roberto Malinverni, Julia Niggemeyer, Michèle Kyncl, Judith Hecker, Charlotta Pagel, Christopher B. Mulholland, Catharina Müller-Thomas, Heinrich Leonhardt, Florian Bassermann, Robert A. J. Oostendorp, Klaus H. Metzeler, Marcus Buschbeck, Katharina S. Götze
Journal: Blood Advances
Blood Adv (2018) 2 (23): 3447–3461.
https://doi.org/10.1182/bloodadvances.2018022053
Published: 2018
Includes: Supplemental data